Cargando…

The Role of Plasminogen Activator Inhibitor 1 in Predicting Sepsis-Associated Liver Dysfunction: An Observational Study

Sepsis-associated liver dysfunction (SALD) is associated with a poor prognosis and increased mortality in the intensive care unit. Bilirubin is one of the components of Sequential Organ Failure Assessment used in Sepsis-3 criteria. Hyperbilirubinemia is a late and non-specific symptom of liver dysfu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Woźnica-Niesobska, Ewa, Leśnik, Patrycja, Janc, Jarosław, Zalewska, Małgorzata, Łysenko, Lidia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049524/ https://www.ncbi.nlm.nih.gov/pubmed/36981754 http://dx.doi.org/10.3390/ijerph20064846

Ejemplares similares

Renin as a Marker of Tissue Perfusion, Septic Shock and Mortality in Septic Patients: A Prospective Observational Study
por: Leśnik, Patrycja, et al.
Publicado: (2022)

Effect of a 3% gelatin solution on urinary KIM-1 levels in patients after thyroidectomy: a preliminary randomized controlled trial
por: Leśnik, Patrycja, et al.
Publicado: (2021)

Does the Serum Concentration of Angiotensin II Type 1 Receptor Have an Effect on the Severity of COVID-19? A Prospective Preliminary Observational Study among Healthcare Professionals
por: Janc, Jarosław, et al.
Publicado: (2022)

Measurement of Serum Levels of 5 Amino Acids and Dimethylamine Using Liquid Chromatography-Tandem Mass Spectrometry in Patients without Septic Associated Acute Kidney Injury and with Septic Associated Acute Kidney Injury Requiring Continuous Renal Replacement Therapy
por: Leśnik, Patrycja, et al.
Publicado: (2022)

Does cognitive function impairment affect the duration of hospitalization and in-hospital mortality in geriatric patients hospitalized for COVID-19?
por: Janc, Jarosław, et al.
Publicado: (2023)

Use of Ultrasound-Guided Interfascial Plane Blocks in Anterior and Lateral Thoracic Wall Region as Safe Method for Patient Anesthesia and Analgesia: Review of Techniques and Approaches during COVID-19 Pandemic
por: Szamborski, Marek, et al.
Publicado: (2022)

Evaluation of the Effectiveness of Modified Pectoral Nerve Blocks Type II (PECS II) for Vascular Access Port Implantation Using Cephalic Vein Venesection
por: Janc, Jarosław, et al.
Publicado: (2021)

Ultrasound-Guided Pectoserratus Plane Block and Superficial Serratus Anterior Plane Block for Subcutaneous Implantable Cardioverter-Defibrillator Implantation: A Comparative Study
por: Szamborski, Marek, et al.
Publicado: (2023)

A Successful Outcome of Veno-Venous Extracorporeal Membrane Oxygenation in Obese Patients with Respiratory Failure in the Course of COVID-19: A Report of Two Cases
por: Janc, Jarosław, et al.
Publicado: (2022)

Analysis of management protocols regarding ineffective maintenance of organ functions in patients treated at the Intensive Care Unit of the University Hospital in Wroclaw
por: Woźnica-Niesobska, Ewa, et al.
Publicado: (2020)

Thrombomodulin, Plasminogen Activator Inhibitor-1 and Protein C Levels, and Organ Dysfunction in Sepsis
por: Katayama, Shinshu, et al.
Publicado: (2019)

Usefulness of plasminogen activator inhibitor-1 as a predictive marker of mortality in sepsis
por: Hoshino, Kota, et al.
Publicado: (2017)

Clinical significance of measuring plasminogen activator inhibitor-1 in sepsis
por: Iba, Toshiaki, et al.
Publicado: (2017)

Cardiovascular Insufficiency, Abdominal Sepsis, and Patients' Age Are Associated with Decreased Paraoxonase-1 (PON1) Activity in Critically Ill Patients with Multiple Organ Dysfunction Syndrome (MODS)
por: Bednarz-Misa, Iwona, et al.
Publicado: (2019)

Single measurement of plasminogen activator inhibitor-1 in sepsis: is it useful for evaluating the severity or prognosis of sepsis?
por: Koyama, Kansuke, et al.
Publicado: (2017)

Circadian Variation of Plasminogen-Activator-Inhibitor-1 Levels in Children with Meningococcal Sepsis
por: Boeddha, Navin P., et al.
Publicado: (2016)

Validating plasminogen activator inhibitor‐1 as a poor prognostic factor in sepsis
por: Hoshino, Kota, et al.
Publicado: (2020)

Plasminogen Activator Inhibitor-1 and Oncogenesis in the Liver Disease
por: Nam, Da-eun, et al.
Publicado: (2021)

Plasminogen Activator Inhibitor 1 for Predicting Sepsis Severity and Mortality Outcomes: A Systematic Review and Meta-Analysis
por: Tipoe, Timothy L., et al.
Publicado: (2018)

Plasminogen System in the Pathophysiology of Sepsis: Upcoming Biomarkers
por: Napolitano, Filomena, et al.
Publicado: (2023)

Changes in plasminogen activator inhibitor-1 (PAI-1) in patients with severe sepsis or septic shock
por: Ikeda, T, et al.
Publicado: (2002)

Evaluation of 12-Lipoxygenase (12-LOX) and Plasminogen Activator Inhibitor 1 (PAI-1) as Prognostic Markers in Prostate Cancer
por: Gondek, Tomasz, et al.
Publicado: (2014)

Localization of Urokinase‐type Plasminogen Activator, Plasminogen Activator Inhibitor‐1, 2 and Plasminogen in Colon Cancer
por: Naitoh, Hiroyuki, et al.
Publicado: (1995)

Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas
por: Hoshino, Masami, et al.
Publicado: (2001)

Local Production of Soluble Urokinase Plasminogen Activator Receptor and Plasminogen Activator Inhibitor‐1 in the Coronary Circulation Is Associated With Coronary Endothelial Dysfunction in Humans
por: Corban, Michel T., et al.
Publicado: (2018)

From Plasminogen to Plasmin: Role of Plasminogen Receptors in Human Cancer
por: Didiasova, Miroslava, et al.
Publicado: (2014)

Advances in sepsis-associated liver dysfunction
por: Wang, Dawei, et al.
Publicado: (2014)

Therapeutic Potential of Targeting Plasminogen Activator Inhibitor-1 in COVID-19
por: Kellici, Tahsin F., et al.
Publicado: (2021)

Sepsis with liver dysfunction and coagulopathy predicts an inflammatory pattern of macrophage activation
por: Anderko, Renee R., et al.
Publicado: (2022)

An In Silico Approach towards the Prediction of Druglikeness Properties of Inhibitors of Plasminogen Activator Inhibitor1
por: Subramanian, Umadevi, et al.
Publicado: (2014)

The effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays
por: Pieters, Marlien, et al.
Publicado: (2017)

Mitochondrial Dysfunction and Immune Cell Metabolism in Sepsis
por: Park, Dae Won, et al.
Publicado: (2017)

Thrombin and plasmin generation in patients with plasminogen or plasminogen activator inhibitor type 1 deficiency
por: Saes, Joline L., et al.
Publicado: (2019)

Plasminogen activator inhibitor is significantly elevated in liver transplant recipients with decompensated NASH cirrhosis
por: Rivas, Gloriany, et al.
Publicado: (2021)

The Broad Variability in Dental Age Observed among Childhood Survivors Is Cancer Specific
por: Proc, Patrycja, et al.
Publicado: (2021)

Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation
por: Gupta, Kamlesh K., et al.
Publicado: (2017)

Retraction: The effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays
Publicado: (2018)

Vitamin D Deficiency is Associated With Increased Plasminogen Activator Inhibitor 1/Plasminogen Activator Inhibitor 2 Ratio in Pregnancy
por: Andersen, Matilde Kanstrup, et al.
Publicado: (2023)

Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Levels in Patients with Acute Paraquat Intoxication
por: Seok, Su-Jin, et al.
Publicado: (2011)

Structural basis of specific inhibition of tissue-type plasminogen activator by plasminogen activators inhibitor-1
por: Gong, Lihu, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4iqpta9fg222ovvgsaijg954rq